BioSig Technologies, Inc.
12424 Wilshire Blvd., Suite 745
Los Angeles, California 90025
March 28, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
Attention: Michael Fay
| Re: | BioSig Technologies, Inc. File No. 333- 230448 (the “Registration Statement”) Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioSig Technologies, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on March 29, 2019, or as soon thereafter as practicable.
| Very truly yours, | ||
| BIOSIG TECHNOLOGIES, INC. | ||
| By: | /s/ Steve Chaussy | |
| Steve Chaussy Chief Financial Officer | ||
cc: Rick A. Werner, Esq., Haynes and Boone, LLP
